Environmental Health Economic Analysis Annotated Bibliography
Details
Research article Cost-benefit analysis (CBA), Cost-effectiveness analysis (CEA)Authors
Kattan M, Stearns SC, Crain EF, Stout JW, Gergen PJ, Evans R 3rd, Visness CM, Gruchalla RS, Morgan WJ, O'Connor GT, Mastin JP, and Mitchell HE
Journal
Journal of Allergy and Clinical Immunology
Summary
The authors of this study calculated the benefits of a home-based environmental remediation for young, asthmatic children. They determined that the intervention, which cost $1,469 per family, led to a statistically significant reduction in asthma-symptom days, unscheduled clinic visits, and use of beta-agonist inhalers. Findings indicated that the intervention is cost-effective when the aim is to reduce asthma symptom days and the associated costs.
Population
Children (6-11 years) enrolled in the Inner City Asthma Study (ICAS) with moderate-to-severe asthma
Health Outcomes
- Respiratory outcomes (asthma)
Environmental Agents
List of Environmental Agents:
- Air pollutants (tobacco smoke)
- indoor allergens (dust mite, cockroach, mold, pets, rodents)
Source of Environmental Agents:
- Allergens from pests (cockroaches, rodents)
- cigarette smoke (secondhand smoke)
Economic Evaluation / Methods and Source
Type:
- Cost-benefit analysis (CBA)
- Cost-effectiveness analysis (CEA)
Cost Measured:
- Healthcare use costs (scheduled/unscheduled medical visits, emergency department visits, inpatient hospital days, medications/pharmaceutical use)
- costs of the intervention which included skin tests, anti-allergen equipment (e.g., impermeable mattress and pillow covers, HEPA vacuum cleaner, HEPA air cleaner, vent filters)
- salary for environmental counselor
- travel costs
- pest management services
Potential Cost Measures:
- School days lost
- days on which caretaker had to change plans due to child's asthma
Benefits Measures:
- Number of asthma-symptom free days
- reduced healthcare costs
Potential Benefits:
- Reduction in health costs and asthma symptom-free days for other household members
Location:
- Cities within the United States — Boston
- New York City
- Chicago
- Dallas
- Seattle
- Tucson
Models Used: (Not available)
Methods Used:
- The authors used incremental cost-effectiveness ratios (ICER) to assess the cost-effectiveness of a home-based environmental allergen and irritant remediation intervention among inner-city children aged 6-11 years with moderate-to-severe-asthma over a two-year study period.
Sources Used:
- Inner-City Asthma Study (ICAS); National Cooperative Inner-City Asthma Study (NCICAS); Medicaid Reimbursement Survey; American Academy of Pediatrics (2001); The cost-effectiveness of an inner-city asthma intervention for children (Sullivan et al., 2002); Kids Inpatient Database (Hospital Cost and Utilization Project, 2000); Drugs for Asthma (The Medical Letter, Vol. 42, 2000); Drug Topics Red Book (2000); Update and First DataBank Price Alert (2000); additional sources cited in publication
Economic Evaluation / Methods and Source
Citation:
- Kattan M, Stearns SC, Crain EF, Stout JW, Gergen PJ, Evans R 3rd, Visness CM, Gruchalla RS, Morgan WJ, O'Connor GT, Mastin JP, and Mitchell HE. 2005. Cost-effectiveness of a home-based environmental intervention for inner-city children with asthma. Journal of Allergy and Clinical Immunology.
- Pubmed
- DOI
NIEHS Funding: (Not available)
Other Funding: (Not available)
to Top